A brand new prescription oral gel, Gelclair, has been launched to alleviate the ache and discomfort related to oral mucositis, a standard facet impact of chemotherapy and radiotherapy for head and neck most cancers sufferers.
The prescription oral gel Gelclair to alleviate ache related to oral mucositis — additionally referred to as “chemo mouth” — has been launched in america, in line with a press launch from Jaguar Well being.
Oral mucositis is irritation of the mouth’s mucous membranes and, in line with Cleveland Clinic, can result in white patches of puss and sores within the mouth. It’s a widespread facet impact of chemotherapy and radiation remedy, with practically 40% of all sufferers handled with chemotherapy creating this complication, per the discharge. Oral mucositis additionally happens in practically 90% of sufferers with head and neck cancers handled with radiotherapy and chemotherapy.
“A key attribute within the administration of head and neck most cancers sufferers with Gelclair is, in my expertise, to delay the onset, which can lower the severity of oral mucositis, permitting the sufferers to proceed assembly their dietary wants with out having to go on a feeding tube, supporting their potential to resist their six weeks of radiation remedy with out having to go to decrease doses or therapy disruption, and to keep away from the necessity for heavy prescription meds for oral mucositis-related ache,” Dr. Maged Ghaly, a radiation oncologist at Northwell Well being Most cancers Institute at Monter Most cancers Heart in North New Hyde Park, New York, stated within the press launch.
The discharge additionally famous that roughly 19% of sufferers with head and neck most cancers handled with radiotherapy could also be hospitalized due to oral mucositis, which can result in a delay in chemotherapy. This will additionally result in a worse prognosis, discount in high quality of life and enhance in affected person administration prices.
The discharge famous findings from a third-party examine on the prices related to mucositis/pharyngitis (irritation of the again of the throat), which occurred in 70.1% of 99 sufferers within the examine with head and neck cancers. On this examine, the incremental prices of oral mucositis in these sufferers exceeded $17,000.
“These of us working within the oncology area know the impression that facet effect-related delays or cessation of most cancers therapy can have on general survival and on the efficacy of therapy,” Catherine Collis, Senior Vice President of Progress Technique at Jaguar Well being, stated within the launch. “Of sufferers with head and neck cancers handled with chemotherapy and radiotherapy who develop oral mucositis, half of the instances are sometimes thought-about extreme — which means oral mucositis of grade 3 or 4, which generally places a affected person within the hospital requiring parenteral vitamin (vitamins into the vein to bypass the digestive system) and IV hydration, and the morbidity and expense related to that.”
In response to the product’s web site, Gelclair is a conveyable gel packet that can be utilized 3 times a day. After stirring in water, the affected person would rinse their mouth with Gelclair for at the very least one minute, spit it out, then wait 30 to 60 minutes earlier than ingesting or consuming.
“Oral mucositis is among the many commonest, painful and debilitating most cancers treatment-related unwanted effects,” Lisa Conte, president and CEO of Jaguar Well being, stated within the launch. “Gelclair is a gel with a mechanical motion indicated for the administration of ache and reduction of ache by adhering to the mucosal floor of the mouth. It coats and protects the oral mucosa, which helps therapeutic.”
For extra information on most cancers updates, analysis and schooling, don’t overlook to subscribe to CURE®’s newsletters right here.
